Julianna M Mastrorilli
Overview
Explore the profile of Julianna M Mastrorilli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simon T, Singer D, Zhang Y, Mastrorilli J, Cervone A, DiCesare E, et al.
Ann Intern Med
. 2024 Jul;
177(8):1028-1038.
PMID: 38976880
Background: Apixaban, rivaroxaban, and warfarin have shown benefit for preventing major ischemic events, albeit with increased bleeding risk, among patients in the general population with atrial fibrillation (AF). However, data...
2.
Fu E, Desai R, Paik J, Kim D, Zhang Y, Mastrorilli J, et al.
Am J Kidney Dis
. 2023 Oct;
83(3):293-305.e1.
PMID: 37839687
Rationale & Objective: Head-to-head data comparing the effectiveness and safety of oral anticoagulants in patients with atrial fibrillation (AF) and advanced chronic kidney disease (CKD) are lacking. We compared the...
3.
Yoshida K, Cai T, Bessette L, Kim E, Lee S, Zabotka L, et al.
Pharmacoepidemiol Drug Saf
. 2023 Sep;
33(1):e5684.
PMID: 37654015
Background: We aimed to determine whether integrating concepts from the notes from the electronic health record (EHR) data using natural language processing (NLP) could improve the identification of gout flares....
4.
Lin K, Singer D, Bykov K, Bessette L, Mastrorilli J, Cervone A, et al.
JAMA Netw Open
. 2023 Mar;
6(3):e234086.
PMID: 36976562
Importance: The development of an optimal stroke prevention strategy, including the use of oral anticoagulant (OAC) therapy, is particularly important for patients with atrial fibrillation (AF) who are living with...
5.
Mansour O, Paik J, Wyss R, Mastrorilli J, Bessette L, Lu Z, et al.
Clin Epidemiol
. 2023 Mar;
15:299-307.
PMID: 36919110
Purpose: Because chronic kidney disease (CKD) is often under-coded as a diagnosis in claims data, we aimed to develop claims-based prediction models for CKD phenotypes determined by laboratory results in...